View Author
patient cancer level breast tumor protein breast cancer response factor bcar 1 tamoxifen status treatment analysis study therapy expression sepsis bcar 1 levels growth vegf levels tamoxifen treatment disease growth factor model survival table concentration value month receptor multivariate chemotherapy base model adjuvant range shock mutation group prognostic breast tumors menopausal status mif levels 160 kda form multivariate analysis macrophage migration relationship tamoxifen therapy death breast cancer patients association angiogenesi elisa outcome correlation tissue kinase bcar 1 protein prognosis hormone result migration univariate antibody study entry tp 53 adult estrogen 78 kda form sample macrophage meningococcal sepsis ratio postmenopausal cytosol grade menopausal meningococcal death group prognostic value
6 Most Recent Publications
|
Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA
(Article)
McKiernan, E. O'Brien, K. Sweep, F.C. Duffy, M.J. Grebenchtchikov, N. Geurts-Moespot, A. Sieuwerts, A.M. Martens, J.W.M. Magdolen, V. Evoy, D. McDermott, E. Crown, J. |
2008-11-04
|
|
Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis
(Article)
Emonts, M. Sweep, F.C. Calandra, T. Grebenchtchikov, N. Geurts-Moespot, A. Knaup, M. Chanson, A.L. Erard, V. Renner, P. Hermans, P.W.M. Hazelzet, J.A. |
2007-05-15
|
|
The prognostic value of BCAR1 in patients with primary breast cancer.
(Article)
Dorssers, L.C.J. Grebenchtchikov, N. Tienoven, D.T. van Geurts-Moespot, A. Span, P.N. Foekens, J.A. Sweep, F.C. Brinkman, A. Look, M.P. Broekhoven, S.P. van Jong, D. de Peters, H.A. Portengen, H. Meijer van Gelder, M.E. Klijn, J.G.M. |
2004-09-15
|
|
Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.
(Article)
Dorssers, L.C.J. Grebenchtchikov, N. Brinkman, A. Look, M.P. Klijn, J.G.M. Geurts-Moespot, A. Span, P.N. Foekens, J.A. Sweep, C.G. |
2004-08-01
|
|
Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer
(Article)
Berns, P.M.J.J. Portengen, H. Vossen, R. Peters, H. Geurts-Moespot, A. Staveren, I.L. van Foekens, J.A. Meijer van Gelder, M.E. Sweep, F.C. Bakker, B. Klijn, J.G.M. Look, M.P. Grebenchtchikov, N. |
2003-01-01
|
|
High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer
(Article)
Foekens, J.A. Peters, H.A. Grebenchtchikov, N. Look, M.P. Meijer van Gelder, M.E. Geurts-Moespot, A. Kwast, Th.H. van der Sweep, C.G. Klijn, J.G.M. |
2001-01-01
|
